Preliminary Multicenter Experience With the Versius Robotic Surgical System for Radical Prostatectomy: Oncological Outcomes With a Minimum 18-Month of Follow-Up

Objective: To report the minimum 18-month follow-up oncological results of the first preliminary descriptive series of robot-assisted radical prostatectomy (RARP) using Versius Robotic Surgical System (VRSS). Material and methods: Data of patients were collected from two Italian centres. Data on demographic variables, surgical results, pre- and postoperative prostatic specific antigen (PSA), needed for post-operative radiotherapy were extracted from the common database. Results: Sixty patients underwent RARP performed by two surgeons at two different centres. Median follow-up time was 29.5 (IQR 23–35) months. Twenty-one (35%) patients had reported positive surgical margins and 18 (30%) presented extracapsular invasion in the final pathology report. Fifty-five (91.7%) patients had undetectable PSA (≤ 0.05 ng/mL) at 40 days follow-up after surgery. Thirteen (21.7%) patients underwent post-operative radiotherapy during our follow-up. Conclusions: Results of our experience with RARP suggest that performing RARP using VRSS oncologic results are comparable with other case studies using other robotic platforms.